EP3746091A4 - Cholestyramine formulations and methods of use - Google Patents

Cholestyramine formulations and methods of use Download PDF

Info

Publication number
EP3746091A4
EP3746091A4 EP19746690.7A EP19746690A EP3746091A4 EP 3746091 A4 EP3746091 A4 EP 3746091A4 EP 19746690 A EP19746690 A EP 19746690A EP 3746091 A4 EP3746091 A4 EP 3746091A4
Authority
EP
European Patent Office
Prior art keywords
methods
cholestyramine
formulations
cholestyramine formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19746690.7A
Other languages
German (de)
French (fr)
Other versions
EP3746091A1 (en
Inventor
Sophie TANGUAY
Smita Debnath
Mustapha KANDIL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pmsci Research And Development Inc
Original Assignee
Pharmascience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmascience Inc filed Critical Pharmascience Inc
Publication of EP3746091A1 publication Critical patent/EP3746091A1/en
Publication of EP3746091A4 publication Critical patent/EP3746091A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/34—Monomers containing two or more unsaturated aliphatic radicals
    • C08F212/36—Divinylbenzene
EP19746690.7A 2018-01-30 2019-01-30 Cholestyramine formulations and methods of use Withdrawn EP3746091A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862623895P 2018-01-30 2018-01-30
PCT/CA2019/050116 WO2019148278A1 (en) 2018-01-30 2019-01-30 Cholestyramine formulations and methods of use

Publications (2)

Publication Number Publication Date
EP3746091A1 EP3746091A1 (en) 2020-12-09
EP3746091A4 true EP3746091A4 (en) 2021-10-06

Family

ID=67477895

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19746690.7A Withdrawn EP3746091A4 (en) 2018-01-30 2019-01-30 Cholestyramine formulations and methods of use

Country Status (4)

Country Link
US (1) US20210077413A1 (en)
EP (1) EP3746091A4 (en)
CA (1) CA3089742A1 (en)
WO (1) WO2019148278A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022248381A1 (en) 2021-05-25 2022-12-01 Evonik Operations Gmbh Hard-shell capsule with influx prevention of gastric fluids

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080311161A1 (en) * 2005-10-11 2008-12-18 Jonathan David Gass Compositions and Methods for Enhanced Gastrointestinal Stability of Oligopeptides and Polypeptides
WO2010079343A2 (en) * 2009-01-09 2010-07-15 Cambridge Enterprise Limited Formulations of viable cells for oral delivery
US20170224720A1 (en) * 2016-02-09 2017-08-10 Albireo Ab Oral cholestyramine formulation and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
SG11201401816SA (en) * 2011-10-28 2014-05-29 Lumena Pharmaceuticals Inc Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
RU2750937C2 (en) * 2016-02-09 2021-07-06 Альбирео Аб Oral cholestyramine composition and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080311161A1 (en) * 2005-10-11 2008-12-18 Jonathan David Gass Compositions and Methods for Enhanced Gastrointestinal Stability of Oligopeptides and Polypeptides
WO2010079343A2 (en) * 2009-01-09 2010-07-15 Cambridge Enterprise Limited Formulations of viable cells for oral delivery
US20170224720A1 (en) * 2016-02-09 2017-08-10 Albireo Ab Oral cholestyramine formulation and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019148278A1 *

Also Published As

Publication number Publication date
EP3746091A1 (en) 2020-12-09
CA3089742A1 (en) 2019-08-08
WO2019148278A1 (en) 2019-08-08
US20210077413A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
EP3775203A4 (en) Oligonucleotide compositions and methods of use thereof
EP3704239A4 (en) Casz compositions and methods of use
EP3790596A4 (en) Oligonucleotide compositions and methods of use thereof
EP3576782A4 (en) Construct-peptide compositions and methods of use thereof
EP3704254A4 (en) Cas12c compositions and methods of use
EP3624773A4 (en) Ophthalmic compositions and methods of use
EP3873387A4 (en) Body engagers and methods of use
EP3749343A4 (en) Formulation and method of use
EP3752166A4 (en) Trialkyne linking agents and methods of use
EP3886853A4 (en) Diarylhydantoin compounds and methods of use thereof
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3740576A4 (en) Therapeutic compositions and methods of making and using the same
EP3638331A4 (en) Three dimensional tissue compositions and methods of use
EP3600372A4 (en) Synthekine compositions and methods of use
EP3852533A4 (en) Pyridazinones and methods of use thereof
EP3638251A4 (en) Bisphosphocin gel formulations and uses thereof
EP3856214A4 (en) Microbial compositions and methods of use
EP3870203A4 (en) Therapeutic combinations of tdfrps and additional agents and methods of use
EP4037715A4 (en) Protein-macromolecule conjugates and methods of use thereof
EP3749691A4 (en) Angptl8-binding agents and methods of use thereof
EP3820482A4 (en) Tumor reduction formulations and methods of use thereof
EP3761989A4 (en) Imidazodiazepinediones and methods of use thereof
EP3840769A4 (en) Cyclosporine compositions and methods of use
AU2018292381A1 (en) Cosmetic compositions and methods of use
EP3765485A4 (en) Immuno-exosomes and methods of use thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200826

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210906

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 1/12 20060101ALI20210831BHEP

Ipc: A61K 9/48 20060101ALI20210831BHEP

Ipc: A61K 31/785 20060101AFI20210831BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PMSCI RESEARCH AND DEVELOPMENT INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220405